UCBJF:OTCMKTS
UCB
236,94 US$
0,00%
(0,00) 1D
7. okt., 16.00.00 GMT-4 · USD
search
Alle symboler
| Symbol | Pris | Ændring | Ændring i % |
|---|
insights_autoGenererer vigtig indsigt for UCBJF...
Åbn
236,94 US$
Høj
236,94 US$
Lav
236,94 US$
Markedsværdi
39,35 mia.
Gns. vol.
138,00
Volumen
0,00
Højeste i 52 uger
345,39 US$
Laveste i 52 uger
228,94 US$
Beta
0,58
Aktier i omløb
194,51 mio.
Antal ansatte
9 t
Åbn
236,94 US$
Høj
236,94 US$
Lav
236,94 US$
Markedsværdi
39,35 mia.
Gns. vol.
138,00
Volumen
0,00
Højeste i 52 uger
345,39 US$
Laveste i 52 uger
228,94 US$
Beta
0,58
Aktier i omløb
194,51 mio.
Antal ansatte
9 t
Nyhedshistorier
Fra webkilder og nyhedspartnere
AD HOC NEWS
·
for 6 timer siden
UCB stock loses 0.61 percent pre-market to EUR 202.30
AD HOC NEWS
·
for 1 dag siden
UCB presents Bimzelx data as UCB stock trades at EUR 201.20
AD HOC NEWS
·
for 1 dag siden
UCB stock pre-market at EUR 202.15: plus 0.07 percent
AD HOC NEWS
·
for 1 dag siden
UCB stock carries first half drug sales into October
Profil
UCB is a multinational biopharmaceutical company headquartered in Brussels, Belgium. UCB is an international company with revenue of €4.178 billion in 2016 which focuses primarily on research and development, specifically involving medications centered on epilepsy, Parkinson's disease, and Crohn's disease. The company's efforts are focused on treatments for severe diseases treated by specialists, particularly in the fields of central nervous system disorders, inflammatory disorders, and oncology.
Every three years, the company presents the UCB Award under the patronage of the Queen Elisabeth Medical Foundation to promote neuroscience research. The winner of this award is selected by an independent scientific committee. Wikipedia
Om UCB
Administrerende direktørJean-Christophe Tellier
Ansatte9 t
Grundlagt18. jan. 1928
Hovedsæde-
Sektor-
Websiteucb.com